Shawbrook is set to price its London initial public offering at the middle of its marketed range, putting it on track to raise about £348 million https://t.co/AlhhGokDQu ...

Outsized gains from Indian initial public offerings seen in the past are fading in 2025, as investors become more picky in what remains one of the world’s hottest IPO markets https://t.co/gyOrR6jZHK ...

Core Points - Apex Treasury Corporation has announced the pricing of its upsized initial public offering (IPO) of 30,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $300,000,000 before underwriters' over-allotment option [1] - Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at $11.50 per share [2] - The units are set to begin trading on Nasdaq under the ticker symbol "APXTU" on October 28, 2025, with the offering expected to close on October 29, 2025, subject to customary closing conditions [3] Company Overview - Apex Treasury Corporation is a blank check company aimed at executing a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination, primarily focusing on opportunities in the digital asset sector [4] Offering Management - Cohen & Company Capital Markets is acting as the sole book-running manager for the offering [5]

Core Points - Apex Treasury Corporation has announced the pricing of its upsized initial public offering (IPO) of 30,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $300,000,000 before the underwriters' over-allotment option [1] - Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at $11.50 per share [2] - The units are set to begin trading on Nasdaq under the ticker symbol "APXTU" on October 28, 2025, with the offering expected to close on October 29, 2025, subject to customary closing conditions [3] Company Overview - Apex Treasury Corporation is a blank check company formed to pursue mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations, with an initial focus on the digital asset sector [4] - Cohen & Company Capital Markets is acting as the sole book-running manager for the offering [5]

Core Points - LaFayette Acquisition Corp. successfully closed its initial public offering, raising total gross proceeds of $115 million by issuing 11,500,000 units priced at $10.00 each, including 1,500,000 units from the underwriters' over-allotment option [1] - The company is a special purpose acquisition company (SPAC) led by Christophe Charlier, aimed at engaging in business combinations with various businesses [2][6] - The units are listed on the Nasdaq under the symbol "LAFAU," with each unit comprising one ordinary share and one right to receive a fraction of an ordinary share upon a business combination [3] Company Overview - LaFayette Acquisition Corp. is organized to effect mergers, share exchanges, asset acquisitions, or similar business combinations with one or more entities [6] - The management team believes it can add value to target businesses across various industries and geographic regions [6] Offering Details - EarlyBirdCapital, Inc. acted as the book-running manager for the offering, while IB Capital served as co-manager [4] - The registration statement for the offering became effective on October 22, 2025, and the offering was conducted via a prospectus [4]

Fractal Analytics is preparing to kick off its initial public offering, which may fetch 49 billion rupees ($555 million), as early as next month in India https://t.co/K54kJJYi6r ...

Seres started taking investor orders for a Hong Kong listing that may raise as much as HK$13.2 billion ($1.7 billion) https://t.co/IvtcAc069V ...

Core Points - MapLight Therapeutics, Inc. has priced its initial public offering (IPO) at $17.00 per share for 14,750,000 shares, with an additional option for underwriters to purchase 2,212,500 shares [1][2] - The total expected gross proceeds from the IPO and a concurrent private placement are approximately $258.9 million, excluding underwriters' options and expenses [2] - The shares are set to begin trading on the Nasdaq Global Market under the symbol "MPLT" on October 27, 2025, with the offering expected to close on October 28, 2025 [3] Company Overview - MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on central nervous system disorders, founded by leaders in psychiatry and neuroscience [7] - The company's lead product candidate, ML-007C-MA, is currently in Phase 2 clinical trials for treating schizophrenia and Alzheimer's disease psychosis [7]

Group 1 - The Company, Harvard Ave Acquisition Corporation, closed its initial public offering of 14,500,000 units at $10.00 per unit, generating gross proceeds of $145 million before deductions [1] - The units began trading on the Nasdaq Global Market under the ticker symbol "HAVAU" on October 23, 2025, with each unit consisting of one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share [1] - The Company is a blank check company incorporated in the Cayman Islands, aiming to pursue a merger, share exchange, asset acquisition, or similar business combination, focusing on industries that complement the management team's background [2] Group 2 - D. Boral Capital LLC acted as the sole book-running manager for the offering, while Robinson & Cole LLP and Winston & Strawn LLP served as legal counsel to the Company and D. Boral Capital LLC, respectively [3] - A registration statement on Form S-1 relating to these securities was filed with the SEC and declared effective on September 30, 2025, with the offering made only by means of a prospectus [4]

IPO Market Decline - London's IPO market has significantly declined since 2006, with the first half of 2025 being the worst since 1998 [1] - The number of companies listed in the UK has fallen by approximately 40% since 2008 [1] - London has fallen out of the top 20 IPO markets due to a 69% slump in fundraising [1] Factors Undermining London's Exchange - UK companies have consistently traded at a discount, recently around 35%, compared to peers in other developed countries, fueling takeovers and an exodus from the London Stock Exchange [10] - The exodus of domestic investors, including pension funds, wealth managers, and retail investors, has contributed to the lackluster UK market [12] - Brexit and post-Brexit political chaos have created reputational damage and deterred foreign investors [18] - The UK charges a stamp duty of 0.5% on share transactions, the highest among major markets, deterring investors [19] - Stringent regulations on the LSE, while ensuring quality, can deter companies from listing [20][21] Potential Solutions and Opportunities - The Investment Association is revising remuneration guidelines, and FTSE 100 CEO pay is growing faster than S&P 500 CEO pay [23] - Ongoing efforts are focused on improving the regulatory and listing environment to attract new companies [23] - London remains the biggest equity market in Europe and a major global financial center [26] - Successful listings of multi-billion dollar companies could change the narrative and attract more interest in the London Stock Exchange [27]